FDA.reportPublic FDA data

oritavancin 400 MG Injection

RxCUI
1547615
RxNorm name
oritavancin 400 MG Injection
Display name
oritavancin 400 MG Injection
Full name
oritavancin 400 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ff09a726-9f9b-4e30-b509-396781293220oritavancin 400 MG Injection [PSN] · oritavancin 400 MG Injection [SCD] · oritavancin (as oritavancin diphosphate) 400 MG Injection [SY]312These highlights do not include all the information needed to use ORBACTIV safely and effectively. See full prescribing information for ORBACTIV. ORBACTIV ® (oritavancin) for injection, for intravenous use Initial U.S. Approval: 201420250717